Rituximab, a monoclonal antibody used primarily in the treatment of certain types of cancer and autoimmune diseases, has become a crucial part of modern therapeutic regimens. As the demand for biologics like rituximab continues to rise, understanding the production costs involved is essential for healthcare providers, pharmaceutical companies, and policymakers. This blog delves into the …
Continue reading “Navigating the Costs of Rituximab Production: A Detailed Report”
